Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 527-532

  Swan, Jonathan W ^a   Anker, Stefan D ^a   Walton, Christopher ^a   Godsland, Ian F ^a   Clark, Andrew L ^a   Leyva, Francisco ^a   Stevenson, John C ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

BLOOD GLUCOSE; CORONARY DISEASE; EPINEPHRINE; GLUCOSE TOLERANCE TEST; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NOREPINEPHRINE; OXYGEN CONSUMPTION; TRIGLYCERIDES;

EID: 0030751957     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00185-X     Document Type: Article

References (22)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
2. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation impairment with increased blood pressure and body mass . Lancet. 342:1993;707-709.
3. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J. 15:1994;1528-1532.
4. Ley CJ, Swan JW, Godsland IF, Walton C, Crook D, Stevenson JC. Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram. J Am Coll Cardiol. 23:1994;377-383.
5. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 236:1979;E667-E677.
6. Swan JW, Walton C, Godsland IF. Assessment of insulin sensitivity in man a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure . Clin Sci. 86:1994;317-322.
7. Volterrani M, Clark AL, Ludman PF, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J. 15:1994;801-809.
8. Landsberg L, Young JB. Catecholamines and the adrenal medulla. Wilson JD, Foster DW. Williams Textbook of Endocrinology. 1992;621-705 Saunders, Philadelphia.
9. Walton C, Godsland IF, Proudler AJ, Felton C, Wynn V. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol. 262:1992;E755-E762.
10. Paolisso G, DeRiu S, Marazzo G, Verza M, Varricchio M, O'Onofrio. Insulin resistance and hyperinsulinaemia in patients with chronic congestive heart failure. Metabolism. 40:1991;972-977.
11. Rowe JW, Young JB, Minaker KL, Stevens AL, Palotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:1981;219-225.
12. Porte D, Graber AL, Kuzuya T, Williams RH. The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest. 45:1966;228-236.
13. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine hormone and neurotransmitter in man . Am J Physiol. 234:1978;E252-E256.
14. Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest. 65:1980;682-689.
15. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 65:1980;717-721.
16. DeFronzo RA. The effect of insulin on renal sodium metabolism a review with clinical implications . Diabetologia. 21:1981;165-171.
17. Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia. 28:1985;70-75.
18. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 55:1985;1037-1042.
19. Tsutamoto T, Hisanaga T, Fukai D, Wada A, Maeda Y, Kinoshita M. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol. 76:1995;803-808.
20. Tsutamoto T, Hisanaga T, Maeda K, Maeda Y, Wada A. Plasma soluble vascular cell adhesion molecule-1 and tumor necrosis factor-α levels as markers of prognosis in patients with congestive heart failure [abstract]. Circulation. 92:(Suppl I):1995;I-331.
21. Anker SD, Swan JW, Volterrani M, Chua TP, Clark AL, Poole-Wilson PA, Coats AJS. The influence of muscle mass, strength, fatiguability and blood flow on exercise capacity in cachectic and non-cachetic patients with chronic heart failure. Eur Heart J. 18:1997;259-269.
22. Anker SD, Swan JW, Chua TP, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia. Circulation. In press.